Opinion · 22 Oct 2024
Conference abstractPublished 2021
Ocular Delivery of Itraconazole-loaded Proniosomal Gels for Effective Control of Ocular Keratitis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Fungal keratitis is the prime cause of ophthalmic mycosis that leads to corneal scarring and vision loss. The unique defensive mechanisms of the eye result in inadequate corneal permeability. Besides, frequent administration of conventional dosage forms may lead to patient incompliance and failure of treatment. The current study focuses on the development of proniosomal gel formulation as a drug carrier to enhance the ocular availability and antimycotic activity of itraconazole for the management of keratitis. Proniosomal gels were prepared using the coacervation phase separation method according to a 32factorial design. The formed gels were homogenous, mucoadhesive, and spreadable. After hydration of proniosomal gels, the resulting niosomes were evaluated in terms of vesicle size, size distribution, surface charge, and encapsulation efficiency. The optimized proniosomal gel comprised of Span® 40 (1800 mg), lecithin (900 mg), and cholesterol (280.7 mg), displayed particle size of 289.567±5.1 nm, PDI of 0.5, the zeta potential of -22.033 ± 1.98 mV, and encapsulation efficiency of 96.9 ± 1.5%. The in vitro antimycotic study revealed a significant increase in the zone of inhibition of Candida albicans culture for the optimized proniosomal gel relative to free itraconazole dispersion. The in vivo antifungal activity was evaluated using an animal model of rabbits’ eyes infected with Candida albicans. Proniosomal gel-treated animals; showed a significant reduction in Candida counts at the days 8 and 12 post-infection compared to free drug dispersion. Hence, the developed proniosomal gel system might provide a promising carrier for ophthalmic drug delivery and improved management of ocular keratitis.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Drug Development and Research.
Opinion · 22 Oct 2024
From Monoclonal Antibodies to CAR-T Therapy: Trends and Transformations in Cancer Treatment
Perspective · 21 Oct 2024
Natural Products in Drug Discovery: From Traditional Remedies to Modern Medicines
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Drug Development and Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Nermin E. Eleraky”
- BylineArticles whose byline prints “Ayat Allam”
- BylineArticles whose byline prints “Hesham M. Tawfeek”
- BylineArticles whose byline prints “Mohamed A. El-Mokhtar”
